Showing results (91-100 of 12,899) with videos related to
Sort By:
Pageof 1,290
Circulation|December 27, 2011
American College of Cardiology/American Heart Association/European Society of Cardiology/World Heart Federation universal definition of myocardial infarction classification system and the risk of cardiovascular death: observations from the TRITON-TIMI 38 trial (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis in Myocardial Infarction 38)Marc P Bonaca, Stephen D Wiviott, Eugene Braunwald, et al.Journal of the American College of Cardiology|April 6, 2004
Association of a pulsatile blood flow pattern on coronary arteriography and short-term clinical outcomes in acute myocardial infarctionC Michael Gibson, Juhana Karha, Sabina A Murphy, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|January 6, 2009
Prognostic utility of apoB/AI, total cholesterol/HDL, non-HDL cholesterol, or hs-CRP as predictors of clinical risk in patients receiving statin therapy after acute coronary syndromes: results from PROVE IT-TIMI 22Kausik K Ray, Christopher P Cannon, Richard Cairns, et al.The American Journal of Cardiology|February 1, 1995
How do smokers differ from nonsmokers in their response to thrombolysis? (the TIMI-4 trial)D Zahger, B Cercek, C P Cannon, et al.Journal of the American College of Cardiology|August 18, 2004
A risk score to estimate the likelihood of coronary artery bypass surgery during the index hospitalization among patients with unstable angina and non-ST-segment elevation myocardial infarctionSaihari Sadanandan, Christopher P Cannon, C Michael Gibson, et al.American Heart Journal|May 3, 2005
Early initiation of lipid-lowering therapy for acute coronary syndromes improves compliance with guideline recommendations: observations from the Orbofiban in Patients with Unstable Coronary Syndromes (OPUS-TIMI 16) trialCharles S Smith, Christopher P Cannon, Carolyn H McCabe, et al.Journal of the American College of Cardiology|October 16, 2010
Prior aspirin use and outcomes in acute coronary syndromesJonathan D Rich, Christopher P Cannon, Sabina A Murphy, et al.Journal of the American College of Cardiology|May 17, 2005
Relative efficacy of atorvastatin 80 mg and pravastatin 40 mg in achieving the dual goals of low-density lipoprotein cholesterol <70 mg/dl and C-reactive protein <2 mg/l: an analysis of the PROVE-IT TIMI-22 trialPaul M Ridker, David A Morrow, Lynda M Rose, et al.Blood|November 24, 2001
Genetic variation in glycoprotein IIb/IIIa (GPIIb/IIIa) as a determinant of the responses to an oral GPIIb/IIIa antagonist in patients with unstable coronary syndromesF F O'Connor, D C Shields, A Fitzgerald, et al.Pageof 1,290